United States Thalidomide Market Report 2017

December 2017 | 101 pages | ID: UD88127A4A8EN
QYResearch

Abstracts

In this report, the United States Thalidomide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Thalidomide in these regions, from 2012 to 2022 (forecast).

United States Thalidomide market competition by top manufacturers/players, with Thalidomide sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Celgene

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Purity:98%
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Leprosy
• Arthropathy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Thalidomide Market Report 2017

1 THALIDOMIDE OVERVIEW

1.1 Product Overview and Scope of Thalidomide
1.2 Classification of Thalidomide by Product Category
  1.2.1 United States Thalidomide Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Thalidomide Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Purity:98%
  1.2.4 Others
1.3 United States Thalidomide Market by Application/End Users
  1.3.1 United States Thalidomide Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Leprosy
  1.3.3 Arthropathy
1.4 United States Thalidomide Market by Region
  1.4.1 United States Thalidomide Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Thalidomide Status and Prospect (2012-2022)
  1.4.3 Southwest Thalidomide Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Thalidomide Status and Prospect (2012-2022)
  1.4.5 New England Thalidomide Status and Prospect (2012-2022)
  1.4.6 The South Thalidomide Status and Prospect (2012-2022)
  1.4.7 The Midwest Thalidomide Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Thalidomide (2012-2022)
  1.5.1 United States Thalidomide Sales and Growth Rate (2012-2022)
  1.5.2 United States Thalidomide Revenue and Growth Rate (2012-2022)

2 UNITED STATES THALIDOMIDE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Thalidomide Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Thalidomide Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Thalidomide Average Price by Players/Suppliers (2012-2017)
2.4 United States Thalidomide Market Competitive Situation and Trends
  2.4.1 United States Thalidomide Market Concentration Rate
  2.4.2 United States Thalidomide Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Thalidomide Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES THALIDOMIDE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Thalidomide Sales and Market Share by Region (2012-2017)
3.2 United States Thalidomide Revenue and Market Share by Region (2012-2017)
3.3 United States Thalidomide Price by Region (2012-2017)

4 UNITED STATES THALIDOMIDE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Thalidomide Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Thalidomide Revenue and Market Share by Type (2012-2017)
4.3 United States Thalidomide Price by Type (2012-2017)
4.4 United States Thalidomide Sales Growth Rate by Type (2012-2017)

5 UNITED STATES THALIDOMIDE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Thalidomide Sales and Market Share by Application (2012-2017)
5.2 United States Thalidomide Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES THALIDOMIDE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Celgene
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Thalidomide Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Celgene Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview

7 THALIDOMIDE MANUFACTURING COST ANALYSIS

7.1 Thalidomide Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Thalidomide

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Thalidomide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Thalidomide Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES THALIDOMIDE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Thalidomide Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Thalidomide Sales Volume Forecast by Type (2017-2022)
11.3 United States Thalidomide Sales Volume Forecast by Application (2017-2022)
11.4 United States Thalidomide Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Thalidomide
Figure United States Thalidomide Market Size (K MT) by Type (2012-2022)
Figure United States Thalidomide Sales Volume Market Share by Type (Product Category) in 2016
Figure Purity:98% Product Picture
Figure Others Product Picture
Figure United States Thalidomide Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Thalidomide by Application in 2016
Figure Leprosy Examples
Table Key Downstream Customer in Leprosy
Figure Arthropathy Examples
Table Key Downstream Customer in Arthropathy
Figure United States Thalidomide Market Size (Million USD) by Region (2012-2022)
Figure The West Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Thalidomide Sales (K MT) and Growth Rate (2012-2022)
Figure United States Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Thalidomide Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Thalidomide Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Thalidomide Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Thalidomide Sales Share by Players/Suppliers
Figure 2017 United States Thalidomide Sales Share by Players/Suppliers
Figure United States Thalidomide Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Thalidomide Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Thalidomide Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Thalidomide Revenue Share by Players/Suppliers
Figure 2017 United States Thalidomide Revenue Share by Players/Suppliers
Table United States Market Thalidomide Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Thalidomide Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Thalidomide Market Share of Top 3 Players/Suppliers
Figure United States Thalidomide Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Thalidomide Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Thalidomide Product Category
Table United States Thalidomide Sales (K MT) by Region (2012-2017)
Table United States Thalidomide Sales Share by Region (2012-2017)
Figure United States Thalidomide Sales Share by Region (2012-2017)
Figure United States Thalidomide Sales Market Share by Region in 2016
Table United States Thalidomide Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Thalidomide Revenue Share by Region (2012-2017)
Figure United States Thalidomide Revenue Market Share by Region (2012-2017)
Figure United States Thalidomide Revenue Market Share by Region in 2016
Table United States Thalidomide Price (USD/MT) by Region (2012-2017)
Table United States Thalidomide Sales (K MT) by Type (2012-2017)
Table United States Thalidomide Sales Share by Type (2012-2017)
Figure United States Thalidomide Sales Share by Type (2012-2017)
Figure United States Thalidomide Sales Market Share by Type in 2016
Table United States Thalidomide Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Thalidomide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Thalidomide by Type (2012-2017)
Figure Revenue Market Share of Thalidomide by Type in 2016
Table United States Thalidomide Price (USD/MT) by Types (2012-2017)
Figure United States Thalidomide Sales Growth Rate by Type (2012-2017)
Table United States Thalidomide Sales (K MT) by Application (2012-2017)
Table United States Thalidomide Sales Market Share by Application (2012-2017)
Figure United States Thalidomide Sales Market Share by Application (2012-2017)
Figure United States Thalidomide Sales Market Share by Application in 2016
Table United States Thalidomide Sales Growth Rate by Application (2012-2017)
Figure United States Thalidomide Sales Growth Rate by Application (2012-2017)
Table Celgene Basic Information List
Table Celgene Thalidomide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celgene Thalidomide Sales Growth Rate (2012-2017)
Figure Celgene Thalidomide Sales Market Share in United States (2012-2017)
Figure Celgene Thalidomide Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thalidomide
Figure Manufacturing Process Analysis of Thalidomide
Figure Thalidomide Industrial Chain Analysis
Table Raw Materials Sources of Thalidomide Major Players/Suppliers in 2016
Table Major Buyers of Thalidomide
Table Distributors/Traders List
Figure United States Thalidomide Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Thalidomide Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Thalidomide Price (USD/MT) Trend Forecast (2017-2022)
Table United States Thalidomide Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Thalidomide Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Thalidomide Sales Volume (K MT) Forecast by Type in 2022
Table United States Thalidomide Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Thalidomide Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Thalidomide Sales Volume (K MT) Forecast by Application in 2022
Table United States Thalidomide Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Thalidomide Sales Volume Share Forecast by Region (2017-2022)
Figure United States Thalidomide Sales Volume Share Forecast by Region (2017-2022)
Figure United States Thalidomide Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources